Filing Details

Accession Number:
0000711377-11-000050
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-02 17:05:02
Reporting Period:
2011-10-31
Filing Date:
2011-11-02
Accepted Time:
2011-11-02 17:05:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187556 M Lon Bohannon Neogen Corp
620 Lesher Place
Lansing MI 48912
President & Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-31 1,898 $9.02 303,344 No 4 M Direct
Common Stock Disposition 2011-10-31 9,898 $38.52 293,446 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2011-10-31 1,898 $0.00 1,898 $9.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
91,686 2011-11-01 No 4 M Direct
Footnotes
  1. The options were granted 11/1/06 as NQ options with 5 year lives. The options vested 20% annually for each of 5 years.